Tong C, Zhang Y, Liu Y, et al. Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma. Blood. 2020;136(14):1632-1644.

Subjects

Subjects :

Humans
Antigens, CD19
Immunotherapy, Adoptive
Receptors, Antigen, T-Cell
T-Lymphocytes
Antigens, CD20 immunology
Lymphoma, B-Cell therapy

Details

Language :

English

ISSN :

1528-0020

Volume :

141

Issue :

15

Database :

MEDLINE

Journal :

Blood

Publication Type :

Academic Journal

Accession number :

37052938

Full Text :

https://doi.org/10.1182/blood.2022017502